Recently added articles from Family Practice News:
Measuring fasting insulin in children deemed unhelpful: data lacking on insulin resistance in kids.(NEWS)
Oct 15, 2009; ... NEW YORK -- There is no reason to test overweight or obese children for insulin resistance, according to an international committee of experts in pediatric endocrinology and diabetes. The panel's conclusions were summarized by five of its members at a joint meeting of the Lawson ...
Prostate cancer therapy raises cardiovascular risk.(MEN'S HEALTH)
Oct 15, 2009; ... BERLIN -- Men treated with endocrine therapy for prostate cancer are at increased risk of developing and dying from several types of cardiovascular disease, according to a large observational analysis of 30,642 Swedish patients. When prostate cancer patients were compared with ...
Pralatrexate approved for peripheral T-Cell lymphoma.(NEWS FROM THE FDA)
Oct 15, 2009; ... Pralatrexate has been approved for use as a single agent for treating patients with refractory or relapsed peripheral T-cell lymphoma, the Food and Drug Administration announced. The first treatment ever approved for this rare, often aggressive type of non-Hodgkin's lymphoma, ...
FDA issues draft guidance for risk evaluation/mitigation plans.(NEWS FROM THE FDA)
Oct 15, 2009; ... The Food and Drug Administration issued its first-ever draft guidance for pharmaceutical manufacturers on how to develop a Risk Evaluation and Mitigation Strategy, which the agency increasingly requires of newly approved drugs and biologics. In 2007, the FDA was granted the ...
Diabetes complications seen in adolescents.(METABOLIC DISORDERS)
Oct 15, 2009; ... NEW YORK -- Early diabetes complications were seen in a significant proportion of 821 adolescents with type 1 diabetes for just 2-5 years. Up to one in five of the adolescents had early indicators of eye, kidney, and/or nerve complications. The findings support early screening ...